NASACORT AQ NASAL SPRAY

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

TRIAMCINOLONE ACETONIDE

Boleh didapati daripada:

SANOFI-AVENTIS (MALAYSIA) SDN. BHD.

INN (Nama Antarabangsa):

TRIAMCINOLONE ACETONIDE

Unit dalam pakej:

1 Units; 1 Units

Dikeluarkan oleh:

AVENTIS PHARMA, HOLMES CHAPEL

Risalah maklumat

_ _
_1 _
_ _
_ CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
NASACORT
®
AQ NASAL SPRAY
_ _
Triamcinolone Acetonide (55 micrograms/dose)
_ _
WHAT IS IN THIS LEAFLET
1. What Nasacort is used for
2. How Nasacort works
3. Before you use Nasacort
4. How to use Nasacort
5. While you are using it
6. Side effects
7. Storage and Disposal of Nasacort
8. Product Description
9.
Manufacturer
and
product
Registration Holder
10. Date of revision
WHAT NASACORT IS USED FOR
Nasal
symptoms
of
allergy
include
sneezing, itching and having a blocked,
stuffy
or
runny
nose.
These
can
be
caused by things such as:
• Animal fur or house dust mites. This
type of allergy can happen at any time
of
the
year
and
is
called
perennial
allergic rhinitis
• Pollen. This type of allergy, such as
hay fever, can be caused by different
pollens in different seasons of the year.
This is called seasonal allergic rhinitis.
HOW NASACORT WORKS
Nasacort
contains
a
medicine
called
triamcinolone acetonide. This belongs
to
a
group
of
medicine
called
corticosteroids which means it is a type
of steroid. It is given as a spray in the
nose
to
treat
nasal
symptoms
of
allergic rhinitis.
BEFORE YOU USE NASACORT
_- When you must not use it _
Do not use Nasacort if:
• You are allergic (hypersensitive) to
triamcinolone acetonide or any of the
other ingredients of Nasacort (listed in
ingredients below)
- You have signs of an allergic include:
a rash (hives), itching, swallowing or
breathing problems, swelling of your
lips, face, throat or tongue.
_ _
_ _
_ _
_- Before you start to use it _
Check with your doctor or pharmacist
before using Nasacort if:
• You have an infection of the nose or
throat that is not treated. If you get
fungal infection while using Nasacort,
stop using the spray until the infection
has been treated.
•
You
have
recently
had
a
nose
operation, or had an injury or ulcer in
the nose
•
You
are
being
transferred
from
steroid injections or tablets to Nasacort
sprays
• You have had any eye conditions
such as glaucoma or cataracts
Contact you

Ciri produk

55
micro
g
rams/dose
_triamcinolone acetonide_
INTRANASAL ROUTE
QUALITATIVE AND QUANTITATIVE COMPOSITION
The active ingredient of Nasacort is triamcinolone acetonide. Bottles
of Nasacort contain either
6.5g or 16.5g suspension (with 3.575 mg or 9.075 mg triamcinolone
acetonide respectively). Each
actuation delivers 55 micrograms of triamcinolone acetonide.
The inactive ingredients are: microcrystalline cellulose, carmellose
sodium, polysorbate 80,
purified water, glucose anhydrous, benzalkonium chloride, edetate
disodium and hydrochloric acid
or sodium hydroxide (for adjustment of pH). The active ingredient is
an anti-allergic corticosteroid.
THERAPEUTIC INDICATIONS
Nasacort AQ Nasal Spray is indicated for the treatment of the nasal
symptoms of seasonal and
perennial allergic rhinitis in adults and children 2 years of age and
older.
POSOLOGY AND METHOD OF ADMINISTRATION
Nasacort is for nasal use only.
PATIENTS AGED 12 YEARS AND OLDER: the recommended starting dose is 220
mcg as 2 sprays in
each nostril, once daily. Once symptoms are controlled patients can be
maintained on 110 mcg
(1 spray in each nostril, once daily).
CHILDREN AGED 6-12 YEARS: the recommended dose is 110 mcg as 1 spray
in each nostril, once
daily. In patients with more severe symptoms, a dose of 220 mcg may be
used. But once
symptoms are controlled, patients should be maintained on the lowest
effective dose.
CHILDREN 2 TO 5 YEARS OF AGE: The recommended and maximum dose is 110
mcg per day given
as one spray in each nostril once daily.
An improvement in some patients symptoms may be seen within the first
day of treatment, and
generally, it takes one week of treatment to reach maximum benefit.
Initial assessment for
response should be made during this time frame and periodically until
the patient’s symptoms are
stabilized. If adequate relief of symptoms has not been obtained after
3 weeks of treatment,
Nasacort AQ Nasal Spray should be discontinued.
Nasacort AQ Nasal Spray is not recommended for children under 2 years
of age.
_Method of administ